Compare Precose vs. Glucovance

Acarbose (Precose) and Glucovance (glyburide/metformin) are both medications used to manage Type 2 diabetes, but they work differently and have distinct characteristics. Acarbose is an alpha-glucosidase inhibitor that slows down the digestion of carbohydrates in your gut, leading to lower blood sugar levels after meals. It is taken three times daily with the first bite of each main meal and is available only as a generic. On the other hand, Glucovance combines two medications: glyburide, a sulfonylurea that stimulates insulin release from the pancreas, and metformin, a biguanide that reduces sugar production in the liver and improves insulin sensitivity. Glucovance is typically taken once or twice daily with meals and is also available as a generic. Acarbose is less likely to cause hypoglycemia when used alone, whereas Glucovance has a higher risk of causing low blood sugar. Additionally, acarbose can cause side effects like gas and diarrhea, while Glucovance can lead to stomach upset and has a rare but serious risk of lactic acidosis. Both medications should be taken with meals. Glucovance requires careful monitoring for low blood sugar, kidney function, and potential heart problems.